Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

Rhea-AI Summary

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) announced its participation in the Bank of America Securities 2021 Virtual Healthcare Conference on May 13, 2021, at 8:45 a.m. ET. Members of the management team will engage in a fireside chat and conduct one-on-one meetings. Interested parties can access the live webcast and a subsequent recording on Phathom's website, available for 90 days post-event. The company focuses on developing treatments for gastrointestinal diseases, including its late-stage candidate, vonoprazan, a novel potassium competitive acid blocker.

FLORHAM PARK, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the Bank of America Securities 2021 Virtual Healthcare Conference on Thursday, May 13, 2021 at 8:45 a.m. ET.  

Company management will also participate in one-on-one meetings during the virtual conference.

To access the live webcast and archived recording of the presentation, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. The recording will be available for 90 days following the event.

About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company’s website at www.phathompharma.com or follow the Company on follow the Company on social media: LinkedIn at www.linkedin.com/company/phathompharma and Twitter @PhathomPharma.

CONTACTS
Media Contact:
Nick Benedetto
1-877-742-8466
media@phathompharma.com

Investor Contact:
Todd Branning
1-877-742-8466
ir@phathompharma.com

FAQ

What is Phathom Pharmaceuticals participating in on May 13, 2021?

Phathom Pharmaceuticals will participate in the Bank of America Securities 2021 Virtual Healthcare Conference on May 13, 2021.

What time is Phathom Pharmaceuticals' presentation at the conference?

The presentation is scheduled for 8:45 a.m. ET on May 13, 2021.

How can I access the Phathom Pharmaceuticals conference presentation?

You can access the live webcast and the archived recording on Phathom's website.

What is vonoprazan and its significance to Phathom Pharmaceuticals?

Vonoprazan is a novel potassium competitive acid blocker that Phathom is developing for acid-related disorders.

How long will the Phathom Pharmaceuticals conference recording be available?

The recording will be available for 90 days following the event.